Skip to main content
Premium Trial:

Request an Annual Quote

Ventana Shareholders Tender 70.5 Percent of Shares to Roche

NEW YORK (GenomeWeb News) – Shareholders of Ventana Medical Systems have tendered 25.5 million shares, or 70.5 percent of Ventana’s outstanding stock, as of the close of the tender offer last night.
 
In January, after several months of pursuing Ventana, Roche finally reached an agreement to acquire the tissue-based diagnostics products firm for approximately $3.4 billion, or $89.50 per share. That was up from its previously rejected bid of $75 per share.
 
Roche said that it has opened a subsequent offering period, which ends 7:00 PM EST on Feb. 15, to acquire the remaining shares that have not been tendered.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.